Research pen
Cibinetide; EPO-derived 11-amino acid peptide
ARA-290 (Cibinetide) is a synthetic peptide derived from the helix B domain of erythropoietin (EPO). It has been structurally modified to enable selective interaction with the EPOR-CD131 receptor complex, commonly referred to as the innate repair receptor (IRR), without engaging pathways associated with erythropoiesis.
For laboratory and research use only. Pen illustration is a visual reference. Confirm the supplied format and batch details with our team.
ARA-290 Pen, 10 mg selected.
A complete reference
ARA-290 (Cibinetide) is a synthetic peptide derived from the helix B domain of erythropoietin (EPO). It has been structurally modified to enable selective interaction with the EPOR-CD131 receptor complex, commonly referred to as the innate repair receptor (IRR), without engaging pathways associated with erythropoiesis.
ARA-290 is an 11-amino-acid peptide engineered from the helix B surface region of erythropoietin. In laboratory settings, it is utilised as a model compound in research involving EPO-derived peptides and EPOR-CD131 receptor interactions.
Chemical reference information: CAS number: 1208243-50-8; Molecular formula: C₅₁H₈₄N₁₆O₂₁; Molecular weight: 1257.3 g/mol. These reference identifiers describe the formulation; the batch-specific analytical record identifies the supplied material.
Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.
Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.
NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.
ARA-290 10 mg is offered as a NORVEXA research pen. The selected strength refers to the compound content of this pen reference. Request the matching batch record for identity, analytical specifications, and presentation details.
Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.
Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.
NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.
Include the printed batch reference when requesting your certificate of analysis. The record applies to the batch supplied to your laboratory.
Prepare a documentation requestContinue exploring
10 mg / 50 mg
5-Amino-1MQ (5-Amino-1-methylquinolinium iodide) is a small molecule compound identified in scientific literature as an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular metabolic pathways. NORVEXA research pen format.
Reference details
5 mg
AOD-9604 (Growth Hormone Fragment 177–191) is a synthetic peptide derived from the C-terminal region of human growth hormone. NORVEXA research pen format.
Reference details
10 mg
ADAMAX is a synthetic peptide analogue derived from the Semax peptide backbone, incorporating N-terminal acetylation and a C-terminal adamantyl group. NORVEXA research pen format.
Reference details